Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis

Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis

AbstractBackground The overall response rate of immunotherapy in triple-negative breast cancer (TNBC) remains unsatisfactory. Accumulating evidence indicated that glucose metabolic reprogramming could modulate immunotherapy efficacy. However, transcriptomic evidence remains insufficient.Methods Gene...

Full description

Bibliographic Details
Main Authors:	Tao Xu, Jiahao Liu, Yu Xia, Zhi Wang, Xingrui Li, Qinglei Gao
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	Annals of Medicine
Subjects:	Triple-negative breast cancer immunotherapy glucose metabolism FDG-PET PD-(L)1
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2021.1937694

Similar Items

LC–MS Based Lipidomics Depict Phosphatidylethanolamine as Biomarkers of TNBC MDA-MB-231 over nTNBC MCF-7 Cells
by: Alan Rubén Estrada-Pérez, et al.
Published: (2022-10-01)

Delivery of miR-424-5p via Extracellular Vesicles Promotes the Apoptosis of MDA-MB-231 TNBC Cells in the Tumor Microenvironment
by: Yueyuan Zhou, et al.
Published: (2021-01-01)

Relationships of 18F-FDG PET with tumor microenvironment immunotypes, especially PD-L1 and CD15 expression, and prognosis in oral squamous cell carcinoma
by: Mai Seki, et al.
Published: (2023-04-01)

Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
by: Paola Ferrari, et al.
Published: (2022-01-01)

Comprehensive analysis of glycolysis mediated pattern clusters and immune infiltration characterization of tumor microenvironment in triple-negative breast cancer
by: Ji Liu, et al.
Published: (2023-04-01)

Advances in PET/CT Imaging for Breast Cancer
by: Dorine de Jong, et al.
Published: (2023-07-01)

Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
by: Aiswarya Chaudhuri, et al.
Published: (2023-05-01)

The Landscape of Targeted Therapies in TNBC
by: Elena Vagia, et al.
Published: (2020-04-01)

Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
by: Hoon Sik Choi, et al.
Published: (2021-08-01)

Cerebral glucose hypometabolism in Tick-Borne Encephalitis, a pilot study in 10 Patients
by: Anelia Dietmann, et al.
Published: (2016-10-01)

Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
by: Jieun Lee
Published: (2023-02-01)

Cdh1 Deficiency Sensitizes TNBC Cells to PARP Inhibitors
by: Junjun Li, et al.
Published: (2022-04-01)

The Potential of PSMA as a Vascular Target in TNBC
by: Amelie Heesch, et al.
Published: (2023-02-01)

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
by: Lijuan Weng, et al.
Published: (2024-03-01)

Bromodomain Protein BRD4-Mediated Mutant p53 Transcription Promotes TNBC Progression
by: Julie Xia Zhou, et al.
Published: (2022-12-01)

1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel
by: Karan Modi, et al.
Published: (2020-08-01)

Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022-04-01)

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
by: Andrew Sulaiman, et al.
Published: (2021-10-01)

The role of 18F-FDG PET/CT in the management of large-vessel vasculitis: applications and limitations in clinical practice
by: Maria V. Mattoli, et al.
Published: (2012-01-01)

Head-to-Head Comparison of [<sup>18</sup>F]PSMA-1007 and [<sup>18</sup>F]FDG PET/CT in Patients with Triple-Negative Breast Cancer
by: Natalia Andryszak, et al.
Published: (2024-02-01)

TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
by: Desh Deepak Singh, et al.
Published: (2021-07-01)

Regional differences in the reduction in cerebral FDG uptake induced by the ketogenic diet
by: O. A. Bennett, et al.
Published: (2022-12-01)

Characterization of bovine <it>FUT7</it> furthers understanding of <it>FUT7</it> evolution in mammals
by: Laporte Benoît, et al.
Published: (2012-08-01)

Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in liver metastasis lesions after colon radical operation
by: Yan Qiao, et al.
Published: (2023-06-01)

Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
by: Nicoletta Cordani, et al.
Published: (2023-03-01)

Radiomics of Tumor Heterogeneity in <sup>18</sup>F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer
by: David Ventura, et al.
Published: (2023-04-01)

VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC
by: Mi Zhang, et al.
Published: (2022-09-01)

Positron Emission Tomography in Breast Cancer
by: Jose Luis Vercher-Conejero, et al.
Published: (2015-03-01)

Diagnostic Performance of Dynamic Whole-Body Patlak [<sup>18</sup>F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph Nodes
by: Matthias Weissinger, et al.
Published: (2023-06-01)

Correlation analysis between 18F-fluorodeoxyglucose positron emission tomography and cognitive function in first diagnosed Parkinson’s disease patients
by: Sun Zhihui, et al.
Published: (2023-06-01)

Intra-tumoral microbial community profiling and associated metabolites alterations of TNBC
by: Yi Wang, et al.
Published: (2023-10-01)

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
by: Seongjae Kim, et al.
Published: (2023-11-01)

Functional PET Neuroimaging in Consciousness Evaluation: Study Protocol
by: Tom Paunet, et al.
Published: (2023-06-01)

Positron Emission Tomography (PET) in Oncology
by: Andrea Gallamini, et al.
Published: (2014-09-01)

Aging and Cerebral Glucose Metabolism: <sup>18</sup>F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients
by: Robert Christopher Subtirelu, et al.
Published: (2023-10-01)

Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma
by: Shama Jaswal, et al.
Published: (2022-06-01)

Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia
by: Dawn C. Matthews, et al.
Published: (2021-01-01)

Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation
by: Andreas Kjaer, et al.
Published: (2013-10-01)

Expression of PD-L1 in triple negative breast cancer
by: Gina James Keorges
Published: (2023-03-01)

BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
by: Teresa Rossi, et al.
Published: (2023-01-01)